Skip to main content
Log in

Naproxen-PC: A GI safe and highly effective anti-inflammatory

  • Research Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript


We have been developing a family of phosphatidylcholine (PC)-associated NSAIDs, which appear to have improved GI safety and therapeutic efficacy in both rodent model systems and pilot clinical trials. As naproxen has been demonstrated to be associated with the lowest cardiovascular adverse events in comparison with both COX-2 selective inhibitors and conventional NSAIDs, we have been developing a Naproxen-PC formulation for evaluation in animal models and clinical trials. We have determined that an oil-based formulation of naproxen and triple strength soy lecithin provides excellent GI protection in both: 1) an acute NSAID-induced intestinal bleeding model in rats pretreated with L-NAME that are intragastrically administered a single dose of naproxen (at a dose of 50 mg/kg) vs the equivalent dose of Naproxen-PC; and 2) a more chronic model (at a naproxen dose of 25 mg/kg BID) in rats that have pre-existing hindpaw inflammation (induced with a intradermal injection of Complete Freund’s Adjuvant/CFA). Both models demonstrate the superior GI safety of Naproxen-PC vs naproxen while this novel formulation had significant anti-inflammatory efficacy to reduce hindpaw edema and the generation of PGE2 in the collected joint synovial fluid. Conclusion: Naproxen-PC appears to induce significantly less GI injury and bleeding in two rodent model systems while maintaining anti-inflammatory and COX-inhibitory activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations


Corresponding author

Correspondence to L. M. Lichtenberger.

Additional information

Received 13 October 2008; accepted 11 November 2008

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lichtenberger, L.M., Romero, J.J., Dial, E.J. et al. Naproxen-PC: A GI safe and highly effective anti-inflammatory. Inflammopharmacol 17, 1–5 (2009).

Download citation

  • Published:

  • Issue Date:

  • DOI: